From: The role of stigma in cannabis use disclosure: an exploratory study
Route most often used, n = 249 | |
 Smoking | 106 (42.6%) |
 Vape | 52 (20.9%) |
 Edible | 35 (14.1%) |
 Tincture | 21 (8.4%) |
 Oil | 12 (4.8%) |
 Capsule | 9 (3.6%) |
 Topical | 5 (2.0%) |
 Lozenge | 1 (.4%) |
 Other | 8 (3.2%) |
Known amount of CBD/THC in products normally consumed, n = 249 | |
 Yes | 196 (78.7%) |
 No | 53 (21.3%) |
Average daily amount of CBD normally consumed, n = 195 | |
 5–20 mg | 106 (54.4%) |
 21–29 mg | 29 (14.9%) |
 > 30 mg | 32 (16.4%) |
 Unknown | 28 (14.4%) |
Average daily amount of THC normally consumed, n = 195 | |
 1–5 mg | 39 (20.0%) |
 5–10 mg | 29 (14.9%) |
 10–20 mg | 37 (19.0%) |
 20–30 mg | 35 (18.0%) |
 > 30 mg | 33 (16.9%) |
 Unknown | 22 (11.3%) |
THC concentration normally consumed, n = 195 | |
 < 2.49% | 14 (7.2%) |
 2.5–9.99% | 18 (9.2%) |
 10–14.99% | 11 (5.6%) |
 15–19.99% | 38 (19.5%) |
 20–24.99% | 38 (19.5%) |
 > 25% | 42 (21.5%) |
 Unknown | 34 (17.4%) |
Number of days cannabis used in last 30 days, n = 248 | |
 1 day or less | 12 (4.8%) |
 2–5 days | 17 (6.9%) |
 5–10 days | 21 (8.5%) |
 11–20 days | 22 (8.9%) |
 21 days or more | 176 (71.0%) |
Frequency of cannabis use on days used, n = 248 | |
 Once | 66 (26.6%) |
 Twice | 50 (20.2%) |
 Three times | 42 (16.9%) |
 Greater than three times | 82 (33.1%) |
 Unknown/do not recall | 8 (3.2%) |
Duration of cannabis use, n = 248 | |
 Less than 1 year | 20 (8.1%) |
 1–5 years | 65 (26.2%) |
 5–10 years | 43 (17.3%) |
 Greater than 10 years | 120 (48.4%) |